Page 1

Є Glenmark LIFE SCIENCES Partnership Innovation , Passion . UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30TH SEPTMBER , 2021 ( in Millions , unless otherwise stated ) Half Year Ended Year Ended Quarter Ended Sr. Particulars No. 30 Sep'21 Unaudited 30 Jun'21 Unaudited 30 Sep'20 Unaudited 30 Sep'21 30 Sep'20 31 Mar 21 Unaudited Unaudited Audited 1 Income Revenue from Operations Other Income Total Income 5,617.61 20.89 5,638.50 5,248.97 39.86 5,288.83 5,208.05 0.12 5,208.17 10,866.58 60.75 10,927.33 9,177.73 0.98 9,178.71 18,851.65 8.11 18,859.76 II Expenses Cost of Materials Consumed 2,417.34 2,599.21 3,245.02 5,016.55 5,064.22 9,761.98 Changes in Inventories of Finished Goods 294.83 ( 5.48 ) ( 305.27 ) 289.35 ( 370.10 ) ( 707.01 ) and Work - in - Progress Employee Benefits Expense 485.67 369.42 424.84 855.09 740.04 1,491.31 Finance Costs 72.26 205.50 219.04 277.76 447.19 875.47 Depreciation and Amortisation Expense 96.65 89.19 83.49 185.84 166.08 333.94 Other Expenses 746.40 681.34 574.28 1,427.74 1,079.96 2,394.63 Total Expenses 4,113.15 3,939.18 4,241.40 8,052.33 7,127.39 14,150.32 III Profit Before Tax ( I - II ) 1,525.35 1,349.65 966.77 2,875.00 2,051.32 4,709.44 IV Tax Expenses Current Tax 365.43 322.43 229.43 687.86 482.51 1,127.46 Deferred Tax Total Tax Expenses 7.91 373.34 18.09 12.64 26.00 33.45 340.52 242.07 713.86 515.96 66.17 1,193.63 > > Profit for the Period / Year ( III - IV ) 1,152.01 1,009.13 724.70 2,161.14 1,535.36 3,515.81 Other Comprehensive Income ( OCI ) Items that will not be reclassified to profit or loss ( a ) Re - measurement of the post- employment benefit obligation ( 1.81 ) ( 1.76 ) ( 1.22 ) ( 3.57 ) ( 4.41 ) ( 7.03 ) ( b ) Income tax relating to the above 0.46 0.44 0.31 0.90 Total Other Comprehensive Loss ( 1.35 ) ( 1.32 ) ( 0.91 ) VII Total Comprehensive Income for the Period / Year ( V + VI ) 1,150.66 1,007.81 723.79 ( 2.67 ) 2,158.47 1.11 ( 3.30 ) 1,532.06 1.77 ( 5.26 ) 3,510.55 VIII Earnings per equity share ( Face Value of 2 / - each ) ( Not Annualised except for the year ended 31st March ) ( a ) Basic ( in ) 9.83 9.36 6.72 19.20 14.24 32.61 ( b ) Diluted ( in ) 9.82 9.36 6.72 19.19 14.24 32.61 IX Paid up Equity Share Capital , Equity 245.05 215.61 19.60 245.05 19.60 19.60 Shares of 2 / - each X Other Equity excluding Revaluation Reserve 7,507.87 See accompanying notes to the Financial Results WALKER CHANDIOK CHARTERED K & CO LLP ACCOUNTAN LIFES GLENMAR NCES * LIMITED Glenmark Life Sciences Limited Corporate Office : 4th Floor , OIA House , 470 , Cardinal Gracious Road , Andheri ( E ) , Mumbai , 400 099 , India . Registered Office : Plot No. 170-172 , Chandramouli Industrial Estate , Mohol Bazarpeth , Solapur - 413 213 , India . T : 91 22 68297979 CIN : U74900PN2011PLC139963 E : complianceofficer@glenmarklifesciences.com W : www.glenmarklifesciences.com